MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-20-2026
Abbott Laboratories Total Current Liabilities 2011-2026 | ABT
Annual Total Current Liabilities Abbott Laboratories
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 16.5 B | 14.2 B | 13.8 B | 15.5 B | 13.1 B | 11.9 B | 10.9 B | 9.01 B | 8.91 B | 6.66 B | 9.19 B | 10.5 B | 9.51 B | 13.3 B | 15.5 B |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 16.5 B | 6.66 B | 11.9 B |
Total Current Liabilities of other stocks in the Medical devices industry
| Issuer | Total Current Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Align Technology
ALGN
|
2.04 B | $ 186.18 | 3.05 % | $ 13.9 B |  USA |
 |
Avinger
AVGR
|
19.3 M | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
65.2 M | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
25.1 M | - | 1.37 % | $ 20.5 M | USA |
 |
AxoGen
AXGN
|
23.6 M | $ 34.29 | 2.45 % | $ 1.58 B | USA |
 |
BioSig Technologies
BSGM
|
42.8 M | - | 37.08 % | $ 85.7 M | USA |
 |
Conformis
CFMS
|
14.1 M | - | - | $ 16.4 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
44.1 M | - | - | $ 1.77 B | USA |
 |
Acutus Medical
AFIB
|
18.9 M | - | -26.83 % | $ 2.62 M | USA |
 |
AdaptHealth Corp.
AHCO
|
712 M | $ 12.75 | 3.45 % | $ 1.72 B | USA |
 |
Allied Healthcare Products
AHPI
|
5.98 M | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
5.05 M | - | -5.86 % | $ 30.6 M | USA |
 |
Bio-Rad Laboratories
BIO
|
468 M | $ 291.88 | 1.29 % | $ 8.24 B | USA |
 |
Cytosorbents Corporation
CTSO
|
9.71 M | $ 0.58 | -0.85 % | $ 36.1 M | USA |
 |
Inogen
INGN
|
63.5 M | $ 6.36 | -1.4 % | $ 169 M | USA |
 |
IRIDEX Corporation
IRIX
|
13.2 M | $ 1.03 | - | $ 17.4 M | USA |
 |
EDAP TMS S.A.
EDAP
|
37.8 M | $ 3.18 | -4.36 % | $ 119 M |  France |
 |
Bruker Corporation
BRKR
|
1.28 B | $ 40.02 | 2.48 % | $ 5.96 K | USA |
 |
Boston Scientific Corporation
BSX
|
5.44 B | $ 63.86 | 1.08 % | $ 94.5 B | USA |
 |
Apollo Endosurgery
APEN
|
39.5 M | - | - | $ 475 M | USA |
 |
LENSAR
LNSR
|
40.6 M | $ 6.05 | 2.2 % | $ 72.3 M | USA |
 |
Cardiovascular Systems
CSII
|
40 M | - | 0.15 % | $ 844 M | USA |
 |
ClearPoint Neuro
CLPT
|
10.8 M | $ 10.32 | 3.1 % | $ 292 M | USA |
 |
Dynatronics Corporation
DYNT
|
8.24 M | - | 14.99 % | $ 929 K | USA |
 |
Second Sight Medical Products
EYES
|
6.6 M | - | -0.97 % | $ 54.4 M | USA |
 |
Myomo
MYO
|
8.35 M | $ 0.77 | 5.33 % | $ 32.2 M | USA |
 |
Electromed
ELMD
|
10.5 M | $ 25.22 | 1.08 % | $ 213 M | USA |
 |
CryoLife, Inc.
CRY
|
60.5 M | - | -4.14 % | $ 702 M | USA |
 |
Soliton, Inc.
SOLY
|
2.82 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
3.19 K | - | -1.98 % | $ 98.3 M | USA |
 |
Sintx Technologies
SINT
|
3.73 M | $ 2.82 | -1.74 % | $ 7.82 M | USA |
 |
GBS
GBS
|
5.35 M | - | -0.57 % | $ 7.12 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
18 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
17.3 M | - | - | $ 462 M | USA |
 |
Globus Medical
GMED
|
498 M | $ 95.08 | 2.26 % | $ 12.9 B | USA |
 |
Stryker Corporation
SYK
|
7.79 B | $ 348.01 | 0.22 % | $ 133 B | USA |
 |
Tactile Systems Technology
TCMD
|
41 M | $ 24.93 | 2.85 % | $ 570 M | USA |
 |
Helius Medical Technologies
HSDT
|
1.88 M | $ 1.98 | -2.49 % | $ 1.2 M | USA |
 |
Butterfly Network
BFLY
|
48.2 M | $ 4.41 | 2.92 % | $ 934 M | USA |
 |
Intersect ENT, Inc.
XENT
|
44.2 M | - | - | $ 955 M | USA |
 |
TransMedics Group
TMDX
|
89.3 M | $ 115.12 | 1.55 % | $ 3.91 B | USA |
 |
BIOLASE
BIOL
|
19.7 M | - | -13.19 % | $ 166 K | USA |
 |
Tandem Diabetes Care
TNDM
|
243 M | $ 20.57 | 2.34 % | $ 1.4 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
46.2 M | $ 17.79 | 4.93 % | $ 417 M | USA |
 |
Delcath Systems
DCTH
|
11 M | $ 10.82 | 3.54 % | $ 388 M | USA |
 |
Inspire Medical Systems
INSP
|
96.1 M | $ 56.35 | 2.6 % | $ 1.65 B | USA |
 |
CONMED Corporation
CNMD
|
315 M | $ 39.75 | 3.35 % | $ 1.23 B | USA |